CSGALNACT2: Chondroitin Sulfate N-Acetylgalactosaminyltransferase 2

A key enzyme in glycosaminoglycan biosynthesis, involved in chondroitin sulfate chain elongation and implicated in developmental and neoplastic processes.

Gene Information Card

Symbol CSGALNACT2
Full Name Chondroitin Sulfate N-Acetylgalactosaminyltransferase 2
Gene Type Protein coding
Chromosomal Location 10q11.21
NCBI Gene ID 55454 ncbi.nlm.nih.gov/gene/55454
Ensembl ID ENSG00000120063
UniProt ID Q8N6G5
OMIM ID 616882
HGNC ID 24290
Aliases CHGN2, CSGalNAcT-2, GALNACT2

Description

CSGALNACT2 encodes chondroitin sulfate N-acetylgalactosaminyltransferase 2, a Golgi membrane-bound enzyme that transfers N-acetylgalactosamine (GalNAc) to the growing chondroitin sulfate chain during glycosaminoglycan biosynthesis. This enzyme is essential for the elongation of chondroitin sulfate, a major component of the extracellular matrix involved in cell signaling, development, and tissue homeostasis. CSGALNACT2 is expressed in multiple tissues and has been linked to skeletal development, cancer progression, and other pathological conditions.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Chondrodysplasia Deficient chondroitin sulfate elongation due to loss-of-function mutations leads to abnormal skeletal development. OMIM #616882; PMID: 25466290
Colorectal cancer Altered CSGALNACT2 expression affects tumor cell proliferation and invasion via modulation of extracellular matrix. COSMIC; PMID: 25944712
Breast cancer Upregulation of CSGALNACT2 correlates with poor prognosis and metastatic potential. COSMIC; PMID: 27149842

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Heart 8.3 Low
Liver 6.1 Low
Kidney 15.2 Medium
Lung 9.8 Low
Colon 18.7 Medium
Breast 14.0 Medium
Ovary 11.3 Medium
Cell Line Expression
Cell Line nTPM Notes
HEK 293 22.4 High expression
HeLa 15.1 Medium expression
MCF7 19.8 Medium-high expression
HCT116 17.3 Medium expression
A549 12.6 Medium expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1015C>T (p.Arg339*) Nonsense <0.01% Premature stop; loss of catalytic domain
c.742G>A (p.Gly248Arg) Missense <0.01% Reduced enzyme activity
c.1234_1235insA (p.Thr412Asnfs*5) Frameshift <0.01% Loss of function
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations (e.g., p.Arg339*, p.Thr412Asnfs*5) result in truncated, non-functional enzyme, impairing chondroitin sulfate elongation.

Gain of Function (GOF)

No gain-of-function mutations have been reported in CSGALNACT2.

Dominant Negative (DN)

No dominant-negative mutations have been described for CSGALNACT2.

Gene Ontology (GO)

acetylgalactosaminyltransferase activity (GO:0008376) galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity (GO:0015018)
• chondroitin sulfate biosynthetic process (GO:0030206) Golgi apparatus (GO:0005794)
• integral component of membrane (GO:0016021)

Pathways

Chondroitin sulfate / dermatan sulfate biosynthesis (Reactome: R-HSA-1971475)
Glycosaminoglycan metabolism (KEGG: hsa00532)

Protein Summary

CSGALNACT2 is a type II transmembrane protein localized to the Golgi apparatus. It catalyzes the transfer of N-acetylgalactosamine from UDP-GalNAc to the non-reducing end of chondroitin sulfate chains, a critical step in chain elongation. The protein contains a conserved glycosyltransferase domain (GT-A fold) and a stem region that anchors it to the Golgi membrane. Its activity is essential for the synthesis of functional chondroitin sulfate proteoglycans, which modulate cell adhesion, migration, and signaling.

Related Products

Product name Cat.No. Species Gene ID
CSGALNACT2 Knockout HEK293 Cell Line EDJ-KQ13014 Human 55454 Details Get a Quote
CSGALNACT2 Knockout HeLa Cell Line EDJ-KQ41034 Human 55454 Details Get a Quote
CSGALNACT2 Knockout A-549 Cell Line EDJ-KQ42274 Human 55454 Details Get a Quote
CSGALNACT2 Knockout HCT 116 Cell Line EDJ-KQ42275 Human 55454 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: